Literature DB >> 2478053

Hyaluronan (hyaluronic acid) in bronchoalveolar lavage fluid during the development of bleomycin-induced alveolitis in the rat.

O Nettelbladt1, R Hällgren.   

Abstract

Hyaluronan (hyaluronate or hyaluronic acid) was measured in bronchoalveolar lavage (BAL) fluid from rats during a 30-day period after a single intratracheal dose of bleomycin. An increase of hyaluronan (HA) in BAL fluid was apparent by 3 days after bleomycin administration. Peak HA values were reached on Day 5 and were about 75 times higher than in control animals. Analyses of urea in BAL and HA in serum indicated that the increased levels of HA in BAL, postbleomycin, could not be explained by plasma leakage. The HA recovered by lavage decreased progressively after Day 5 and returned to normal 3 wk after bleomycin treatment. The HA content and an increased influx of PMN in BAL fluid were correlated and showed a similar time dependence, suggesting that enhanced synthesis of HA in the smaller airways is linked to the early inflammatory phase of the bleomycin injury.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478053     DOI: 10.1164/ajrccm/140.4.1028

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  30 in total

1.  Extracellular matrix components in bronchoalveolar lavage fluid in quartz exposed rats.

Authors:  A Eklund; G Tornling; E Blaschke; T Curstedt
Journal:  Br J Ind Med       Date:  1991-11

Review 2.  Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology.

Authors:  Frances E Lennon; Patrick A Singleton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

Review 3.  Modulators of inflammation in Bronchopulmonary Dysplasia.

Authors:  Rashmin C Savani
Journal:  Semin Perinatol       Date:  2018-10-02       Impact factor: 3.300

Review 4.  Special article: the endothelial glycocalyx: emerging concepts in pulmonary edema and acute lung injury.

Authors:  Stephen R Collins; Randal S Blank; Lindy S Deatherage; Randal O Dull
Journal:  Anesth Analg       Date:  2013-07-08       Impact factor: 5.108

Review 5.  Extracellular superoxide dismutase in pulmonary fibrosis.

Authors:  Fei Gao; Vuokko L Kinnula; Marjukka Myllärniemi; Tim D Oury
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

6.  Hyaluronan (hyaluronic acid) in lung lavage of asbestos-exposed humans and sheep.

Authors:  A M Cantin; P Larivée; M Martel; R Bégin
Journal:  Lung       Date:  1992       Impact factor: 2.584

7.  Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan.

Authors:  Fei Gao; Jeffrey R Koenitzer; Jacob M Tobolewski; Dianhua Jiang; Jiurong Liang; Paul W Noble; Tim D Oury
Journal:  J Biol Chem       Date:  2007-12-28       Impact factor: 5.157

8.  The adenosine a2a receptor inhibits matrix-induced inflammation in a novel fashion.

Authors:  Kara A Scheibner; Sada Boodoo; Samuel Collins; Katharine E Black; Yee Chan-Li; Paul Zarek; Jonathan D Powell; Maureen R Horton
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-14       Impact factor: 6.914

9.  Concentration and turnover of intraperitoneal hyaluronan during inflammation.

Authors:  G A Edelstam; U B Laurent; O E Lundkvist; J R Fraser; T C Laurent
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

10.  Reprint of: A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease.

Authors:  Mary Y Chang; Yoshinori Tanino; Veronika Vidova; Michael G Kinsella; Christina K Chan; Pamela Y Johnson; Thomas N Wight; Charles W Frevert
Journal:  Matrix Biol       Date:  2014-04-12       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.